Gujarat Inject (Kerala) Ltd
Incorporated in 1991, Gujarat Inject Kerala Ltd manufactures pharmaceutical products
- Market Cap ₹ 23.1 Cr.
- Current Price ₹ 15.8
- High / Low ₹ 17.6 / 7.45
- Stock P/E 289
- Book Value ₹ 7.55
- Dividend Yield 0.00 %
- ROCE 2.64 %
- ROE 2.08 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Company has high debtors of 188 days.
- Working capital days have increased from -1,478 days to 354 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2007 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2.33 | 0.00 | 0.00 | 0.02 | 1.57 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.17 | 5.79 | |
2.26 | 0.00 | 0.00 | 0.02 | 1.56 | 0.07 | 0.03 | 0.01 | 0.13 | 0.07 | 0.54 | 5.74 | |
Operating Profit | 0.07 | 0.00 | 0.00 | 0.00 | 0.01 | -0.07 | -0.03 | -0.01 | -0.12 | -0.05 | -0.37 | 0.05 |
OPM % | 3.00% | 0.00% | 0.64% | -1,200.00% | -250.00% | -217.65% | 0.86% | |||||
0.12 | 0.00 | 0.00 | 2.30 | 0.00 | 0.05 | 0.02 | 0.01 | 0.01 | 0.05 | 0.43 | 0.06 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | -0.29 | 0.00 | 0.00 | 2.30 | 0.01 | -0.02 | -0.01 | 0.00 | -0.11 | 0.00 | 0.06 | 0.11 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 16.67% | 18.18% | ||||
-0.29 | 0.00 | 0.00 | 2.30 | 0.01 | -0.02 | -0.01 | 0.00 | -0.11 | 0.00 | 0.04 | 0.08 | |
EPS in Rs | -0.59 | 0.00 | 0.00 | 4.69 | 0.02 | -0.04 | -0.02 | 0.00 | -0.22 | 0.00 | 0.08 | 0.07 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 733% |
TTM: | 3306% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 58% |
3 Years: | 40% |
TTM: | 100% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 96% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 2% |
Balance Sheet
Figures in Rs. Crores
Mar 2007 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 11.29 |
Reserves | -23.13 | -7.64 | -7.95 | -5.64 | -5.64 | -5.66 | -5.66 | -5.66 | -5.77 | -5.76 | -5.72 | -2.75 |
23.89 | 2.55 | 2.86 | 0.56 | 0.57 | 0.59 | 0.59 | 0.59 | 0.69 | 0.73 | 0.61 | 0.00 | |
0.54 | 0.38 | 0.38 | 0.36 | 0.20 | 0.21 | 0.20 | 0.20 | 0.22 | 0.22 | 0.53 | 0.15 | |
Total Liabilities | 6.18 | 0.17 | 0.17 | 0.16 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.07 | 0.30 | 8.69 |
5.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
0.89 | 0.17 | 0.17 | 0.16 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.07 | 0.30 | 8.69 | |
Total Assets | 6.18 | 0.17 | 0.17 | 0.16 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.07 | 0.30 | 8.69 |
Cash Flows
Figures in Rs. Crores
Mar 2007 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | -0.11 | 0.00 | 0.05 | -5.83 | |
-0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 8.69 | |
Net Cash Flow | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 2.86 |
Ratios
Figures in Rs. Crores
Mar 2007 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 40.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 187.86 | |||||
Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 40.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 187.86 | |||||
Working Capital Days | 50.13 | -3,832.50 | -48.82 | -7,300.00 | -3,650.00 | -1,137.94 | 354.28 | |||||
ROCE % | -5.01% | 2.64% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
20 Jul - Confirmation certificate and details of share certificates dematerialized for a period ended on June 30, 2024, received from Bigshare Services Private Limited, Registrar and share …
- Intimation Informing The Approval Of Application For Reclassification From 'PROMOTER' Category To 'PUBLIC' Category 4 Jul
- Closure of Trading Window 26 Jun
- Intimation Of Contact Details Of Key Managerial Personnel Pursuant To Regulation 30(5) Of SEBI (LODR) Regulations, 2015 10 Jun
- Appointment of Company Secretary and Compliance Officer 10 Jun
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2011
from bse
-
Financial Year 2007
from bse
-
Financial Year 2005
from bse
-
Financial Year 2004
from bse
-
Financial Year 2003
from bse
-
Financial Year 2002
from bse
Business Overview:[1]
Company is jointly promoted by Kerala State Industrial Development Corporation Limited,
a wholly owned subsidiary of Government of Kerala and Gujarat Inject Limited. Company manufactures and sells bulk drugs, formulations, chemicals, medicinal preparation, intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipment viz., disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes, diagnostic kits, etc.